Burney CO Eli Lilly & CO Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Burney CO holds 33,070 shares of LLY stock, worth $26.3 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

33,070

Previous 34,465 4.05%

Holding current value

$26.3 Million

Previous $31.2 Million 6.11%

% of portfolio

1.15%

Previous 1.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $1.08 Million - $1.34 Million	-1,395 Reduced 4.05%	33,070 $29.3 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $1.56 Million - $1.96 Million	-2,151 Reduced 5.87%	34,465 $31.2 Million
Q1 2024 May 22, 2024	SELL	$592.2 - $792.28 $306,759 - $410,401	-518 Reduced 1.39%	36,616 $28.5 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $345,049 - $406,768	-657 Reduced 1.74%	37,134 $21.6 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $267,775 - $369,168	-616 Reduced 1.6%	37,791 $20.3 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $284,099 - $379,873	-810 Reduced 2.07%	38,407 $18 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $556,338 - $653,392	-1,791 Reduced 4.37%	39,217 $13.5 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $1.45 Million - $1.69 Million	-4,510 Reduced 9.91%	41,008 $15 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $783,596 - $892,990	-2,643 Reduced 5.49%	45,518 $14.7 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $409,454 - $480,759	-1,469 Reduced 2.96%	48,161 $15.6 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $32,152 - $39,957	-137 Reduced 0.28%	49,630 $14.2 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $72,176 - $89,571	-321 Reduced 0.64%	49,767 $13.7 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $118,112 - $145,354	-533 Reduced 1.05%	50,088 $11.6 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $1.85 Million - $2.4 Million	-10,271 Reduced 16.87%	50,621 $11.6 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $910,168 - $1.18 Million	-5,539 Reduced 8.34%	60,892 $11.4 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $509,968 - $674,810	-3,909 Reduced 5.56%	66,431 $11.2 Million
Q3 2020 Dec 14, 2020	SELL	$146.22 - $169.13 $423,160 - $489,462	-2,894 Reduced 3.95%	70,340 $10.4 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $3.9 Million - $4.69 Million	-28,589 Reduced 28.08%	73,234 $12 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $721,919 - $893,530	-6,064 Reduced 5.62%	101,823 $14.1 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $91,202 - $112,962	853 Added 0.8%	107,887 $14.2 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $611,693 - $665,364	-5,728 Reduced 5.08%	107,034 $12 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $691,994 - $807,732	-6,246 Reduced 5.25%	112,762 $12.5 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $467,056 - $549,759	-4,196 Reduced 3.41%	119,008 $15.4 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $239,334 - $268,126	2,260 Added 1.87%	123,204 $14.3 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $1.93 Million - $2.41 Million	-22,496 Reduced 15.68%	120,944 $13 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $1.45 Million - $1.67 Million	19,175 Added 15.43%	143,440 $12.2 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $1.79 Million - $2.11 Million	-24,074 Reduced 16.23%	124,265 $9.61 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $1.19 Million - $1.28 Million	14,565 Added 10.89%	148,339 $12.5 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $191,596 - $212,652	-2,486 Reduced 1.82%	133,774 $11.4 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $10.5 Million - $11.7 Million	136,260	136,260 $11.3 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account